NFE2L2 and hepatocellular carcinoma: These results, are the first, to our knowledge, to estimate genetic polymorphisms of NRF2 the risk of CHB, HBV-associated LC and HCC, and suggest the potential relevance of rs6721961 polymorphism in HCC susceptibility and the progression of this disease.